TY - JOUR
T1 - Perspectives in immunotherapy
T2 - Meeting report from the "Immunotherapy Bridge", Napoli, December 5th 2015
AU - Ascierto, Paolo A.
AU - Ascierto, Maria Libera
AU - Formenti, Silvia
AU - Gnjatic, Sacha
AU - Hammers, Hans
AU - Hirsh, Vera
AU - Kiessling, Rolf
AU - Melero, Ignacio
AU - Nanda, Rita
AU - Pawelec, Graham
AU - Pignata, Sandro
AU - Romero, Pedro
AU - Speiser, Daniel E.
AU - Fox, Bernard A.
AU - Marincola, Francesco M.
N1 - Publisher Copyright:
© 2016 The Author(s).
PY - 2016/10/18
Y1 - 2016/10/18
N2 - Harnessing the immune system and preventing immune escape, the immunotherapy of cancer provides great potential for clinical application, in broad patient populations, achieving both conventional and unconventional clinical responses. After the substantial advances in melanoma, the focus of cancer immunotherapy has expanded to include many other cancers. Targeting immune checkpoints and further mechanisms used by tumors to avoid anticancer immunity, different approaches are under evaluation, including combination therapies. The first Immunotherapy Bridge meeting focused on various cancer types including melanoma, non-small cell lung cancer, renal cell, breast and ovarian carcinoma, and discussed mechanisms of action of single agents and combination strategies, and the prediction of clinical responses.
AB - Harnessing the immune system and preventing immune escape, the immunotherapy of cancer provides great potential for clinical application, in broad patient populations, achieving both conventional and unconventional clinical responses. After the substantial advances in melanoma, the focus of cancer immunotherapy has expanded to include many other cancers. Targeting immune checkpoints and further mechanisms used by tumors to avoid anticancer immunity, different approaches are under evaluation, including combination therapies. The first Immunotherapy Bridge meeting focused on various cancer types including melanoma, non-small cell lung cancer, renal cell, breast and ovarian carcinoma, and discussed mechanisms of action of single agents and combination strategies, and the prediction of clinical responses.
UR - http://www.scopus.com/inward/record.url?scp=84998817180&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84998817180&partnerID=8YFLogxK
U2 - 10.1186/s40425-016-0168-3
DO - 10.1186/s40425-016-0168-3
M3 - Article
AN - SCOPUS:84998817180
SN - 2051-1426
VL - 4
JO - Journal for immunotherapy of cancer
JF - Journal for immunotherapy of cancer
IS - 1
M1 - 62
ER -